Evning Exposure to Computer Screen Disrupts Sleep, Attention and Biological Rhythms
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 19
- 主要终点
- Karolinska Sleep Questionnaire (KSS)-Subjective sleepiness
研究概览
简要总结
Light exposure is on the rise in recent years. In large part because of unintentional illumination from screens that emit light directly into the eyes. Millions of computers, tablets, televisions, and smart-phones are sold worldwide every month and the usage time of these devices is increasing constantly. Today, people are exposed to ongoing light exposure from these device screens, emitting short wave length (SWL) during day and night hours, whether as active or passive users. In sum, artificial light at night (ALAN) seem to affect human circadian rhythmicity (melatonin and thermoregulation) and sleep, with two major factors. First, wavelength of light, with SWL being most detrimental to sleep and rhythms, when compared to LWL (Brianard et al., 2001). Second, a dose-response relationship exists between increasing light intensity and poorer sleep/circadian rhythms (Brianard et al., 1988; West et al., 2011).
Based on existing knowledge, we hypothesize that when compared to long wavelength LWL illumination, short wavelength SWL illumination from computer screen will have a more damaging effect on melatonin (MLT) production and secretion, interfering body temperature regulation and affecting sleep quality, efficiency and sleep architecture. In addition, we hypothesized that intensity of the screen illumination will play another important factor on these outcomes, we assume that high intensity compared to low intensity will have more damaging effect on: melatonin, thermoregulation and sleep.
详细描述
Methods:
Participants Participants were between the ages of 20 and 45 years, with BMI 18-25, regular sleep habits in Pittsburgh Sleep Quality Index (PSQI) questionnaire index<5 (Buysse et al., 1989, Shochat et al., 2007), and a normative sleep-wake cycle type (Horne-Ostberg morningness-eveningness questionnaire (Horne & Ostberg, 1976, Lavie & Segal, 1990) measured Sleep quality and continuity were measured for one week using actigraphy with compatible decoding software (Respironics Model II, Philips, Inc). Only participants with 6-8 hours of sleep, normative sleep patterns, and no sleep/wake schedule problems proceeded to the experimental phase of the study stage. Participants were healthy with no history of medical, neurological, sleep disorders (confirmed by polysomnography) or psychiatric conditions and no medication intake (excluding contraceptives for female participants). Participants with ocular damage, such as to their field of vision, color blindness, or impaired functioning of the pupil in reaction to light were excluded, however use of eyeglasses or contact lenses to correct vision was allowed. Participants signed informed consent prior to participation in the study. The study was approved by the Helsinki Committee of Assuta Medical Center and Maccabi Health Services.
Measurements
Three physiological measures were collected in the study:
Polysomnography: The sleep testing room was a standard test room at the Sleep Medicine Research Center at Assuta Medical Center. Standard in-lab polysomnography was conducted using the Somnoscreen-polysomnography (PSG) type sleeping test instrument (Somnomedics, Germany). Sleep channels included: electroencephalography (EEG), electro-oculography (EOG), leg and chin electromyography (EMG), nasal breathing, chest breathing, diaphragm breath, snoring, electro-cardio-graphy (EKG), heart rate, blood oxygen saturation, and body position. Sleep data processing was performed by skilled and trained sleep technicians in accordance with of the Rechtschaffen and Kales criteria (1968). Sleep continuity parameters: latency to stage 1 (SL1) and stage 2 (SL2), percent wake after sleep onset (%WASO), index of awakenings, total sleep time (TST), time in bed (TIB), and sleep efficiency (SE). Sleep architecture parameters: percent stage 1 (%S1), stage 2 (%S2), REM (%REM), and SWS (%SWS), index of sleep stage changes and REM onset latency (ROL).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 20 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •regular sleep habits in Pittsburgh Sleep Quality Index (PSQI) questionnaire index<5 normative sleep-wake cycle type (Horne-Ostberg morningness-eveningness questionnaire) 6-8 hours of sleep, normative sleep patterns, and no sleep/wake schedule.
排除标准
- •participants with ocular damage, such as to their field of vision, color blindness, or impaired functioning of the pupil in reaction to light were excluded.
研究组 & 干预措施
intensity
Luminance at two levels: low - 80 lux (35mw/cm2) and high - 350 lux (160mw/cm2).
干预措施: Intensity (Other)
wavelength
Wavelength at two levels: short (SWL)-485 nm (13500k) and long (LWL)-620 nm (4250k)
干预措施: Wavelength (Other)
wavelength
Wavelength at two levels: short (SWL)-485 nm (13500k) and long (LWL)-620 nm (4250k)
干预措施: Intensity (Other)
intensity
Luminance at two levels: low - 80 lux (35mw/cm2) and high - 350 lux (160mw/cm2).
干预措施: Wavelength (Other)
结局指标
主要结局
Karolinska Sleep Questionnaire (KSS)-Subjective sleepiness
时间窗: 1 day
KSS questionaire - number
Epworth Sleepiness Scale (ESS) questionire- Sleepiness
时间窗: 1 day
Epworth Sleepiness Scale (ESS) questionire score- Number
Brief Symptom Inventory (BSI)- questionaire
时间窗: 1 day
Assess the subjects emotional state- number
Attention
时间窗: 1hour
continuous performance test (CPT-III) a computerized attention and concentration test. number
Stage 1% TIB
时间窗: 1 night
Percentage of sleep stage 1 from time in bed, physiological marker
Stage 2% TIB
时间窗: 1 night
Percentage of sleep stage 2 from time in bed, physiological marker
Body temperature
时间窗: 12 hours
Oral body temperature, physiological marker
Total Sleep Time
时间窗: 1 night
Total sleep time in minute. physiological marker
sleep efficiency
时间窗: 1 night
Percentage of sleep efficiency , physiological marker
Wake% TIB
时间窗: 1 night
Percentage of wake from time in bed, physiological marker
Melatonin secretion
时间窗: 12 hours
Melatonin - Sulfate Urine ELISA 6-SMT ng/ml, physiological marker
Sleep latency to stage 2
时间窗: 1 night
Tine in minute to sleep stage 2, physiological marker
Sleep latency to stage 1
时间窗: 1 night
Tine in minute to sleep stage 1, physiological marker
SWS% TIB
时间窗: 1 night
Percentage of sleep stage SWS from time in bed, physiological marker
次要结局
未报告次要终点
研究者
Lilach Kemer
Dr. Lilach Kemer
Assuta Medical Center
